NOACs compare favourably to warfarin in new studies

NOACs compare favourably to warfarin in new studies

June 22 2016 Two BMJ studies have further supported the use of alternatives to warfarin for...

Insulin used with metformin appears more protective than insulin alone in type 2 diabetes

Insulin used with metformin appears more protective than insulin alone in type 2 diabetes

May 11 2016 Serious health risks in type 2 diabetes may be reduced more effectively with insulin...

Cheaper options for methotrexate/DMARD combination for rheumatoid arthritis proposed

Cheaper options for methotrexate/DMARD combination for rheumatoid arthritis proposed

April 27 2016 Methotrexate in combination with sulphasalazine and hydroxychloroquine has been...

SGLT2 and diabetic ketoacidosis risk among MHRA drug safety updates

SGLT2 and diabetic ketoacidosis risk among MHRA drug safety updates

April 20 2016 Patients taking sodium-glucose co-transporter 2 (SGLT2) inhibitors (canagliflozin,...

Cochrane concludes daily iron supplements improves women’s overall activity

Cochrane concludes daily iron supplements improves women’s overall activity

April 20 2016 A Cochrane review has concluded that daily iron supplementation effectively reduces...

  • NOACs compare favourably to warfarin in new studies

    NOACs compare favourably to warfarin in new studies

    Wednesday, 22 June 2016 14:14
  • Insulin used with metformin appears more protective than insulin alone in type 2 diabetes

    Insulin used with metformin appears more protective than insulin alone in type 2 diabetes

    Wednesday, 11 May 2016 14:15
  • Cheaper options for methotrexate/DMARD combination for rheumatoid arthritis proposed

    Cheaper options for methotrexate/DMARD combination for rheumatoid arthritis proposed

    Wednesday, 27 April 2016 13:22
  • SGLT2 and diabetic ketoacidosis risk among MHRA drug safety updates

    SGLT2 and diabetic ketoacidosis risk among MHRA drug safety updates

    Wednesday, 20 April 2016 13:25
  • Cochrane concludes daily iron supplements improves women’s overall activity

    Cochrane concludes daily iron supplements improves women’s overall activity

    Wednesday, 20 April 2016 13:18

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

APPROVEDFebruary 17 2016

 

 

The latest medicines approved for use by the Scottish Medicines Consortium are:

  • guanfacine hydrochloride (Intuniv) - for treating ADHD in children and adolescents 6-17 years old where stimulants are not useful, as part of a comprehensive ADHD treatment programme;
  • golimumab (Simponi) - for treating adults with severe, active nr-axSpA (axial spondyloarthritis) in certain circumstances and where NSAIDs are not useful;
  • panobinostat (Farydak) - for use in combination with bortezomib and dexamethasone in adults with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent;
  • ulipristal acetate (Esmya) - for the intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age;
  • fulvestrant (Faslodex) - for treating post-menopausal women with oestrogen receptor positive, locally advanced or metastatic breast cancer for disease relapse on or after adjuvant anti-oestrogen therapy, or disease progression on therapy with an anti-oestrogen.

In addition, the SMC has not recommended eculizumab (Soliris) for the treatment of adults and children with atypical haemolytic uraemic syndrome (aHUS)

Links:

SMC announcement

SMC February Briefing Note

Clinical News

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as at GP practices, the New NHS Alliance has proposed.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...